| Literature DB >> 23826253 |
Xiaoqin Hu1, Ping Yuan, Jin Yan, Fei Feng, Xiaoling Li, Wenhui Liu, Yanfang Yang.
Abstract
As insulin resistance (IR) is an established risk factor for colorectal cancer (CRC), we explored the association between each of the IR-related gene polymorphisms of adiponectin (ADIPOQ) rs2241766, uncoupling protein 2 (UCP2) rs659366, and fatty acid-binding protein (FABP2) rs1799883 and CRC risk. Genotyping of blood samples and collection of lifestyle and dietary habits were performed for 400 case-control pairs. Unconditional logistic regression (ULR) was applied to assess the effects of the three single nucleotide polymorphisms (SNP), environmental factors. Both ULR and generalized multifactor dimensionality reduction (GMDR) were used to test the gene-gene and gene-environment interactions on CRC risk. Subjects carrying the ADIPOQ rs2241766 TG+GG genotype had a higher CRC risk than those carrying the TT genotype (OR = 1.429, 95% CI 1.069-1.909). The additive and multiplicative interactions between ADIPOQ rs2241766 and FABP2 rs1799883 on CRC were found by ULR (RERI = 0.764, 95%CI 0.218∼1.311, AP = 0.514, 95%CI 0.165∼0.864, S = -1.745, 95%CI is unachievable, and Pmulti = 0.017, respectively). Furthermore, the high order gene-gene interaction of the three SNPs were found by GMDR (P = 0.0107). A significant dosage effect with an increasing number of risk genotypes was observed as the risk of CRC increased (Ptrend = 0.037). In GMDR, the gene-environment interaction among the three SNPs and red meat consumption on CRC risk was significant (P = 0.0107). Compared with subjects with low red meat consumption and null risk genotypes, those with high-red meat consumption and three risk genotypes had 3.439-fold CRC risk (95% CI 1.410-8.385). In conclusion, the results showed that the ADIPOQ rs2241766 TG+GG genotype increased CRC risk. Given the complexity of the carcinogen for CRC, ADIPOQ rs2241766, UCP2 rs659366, FABP2 rs1799883 and red meat consumption potentially worked together in affecting CRC risk.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23826253 PMCID: PMC3695067 DOI: 10.1371/journal.pone.0067275
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primer sequences and reaction conditions for PCR-PFLP of ADIPOQ rs2241766, UCP2 rs659366, and FABP2 rs1799883.
| Gene | Primer sequence | T | Enzyme | Size |
| rs2241766 | F | 58 |
| T: 372 |
| R | G: 219, 153 | |||
| rs659366 | F:5′-CACGCTGCTTCTGCCAGGAC-3′ | 68 |
| G: 295, 68 |
| R:5′-AGGCGTCAGGAGATGGACCG-3 | A: 363 | |||
| rs1799883 | F:5′- ACAGGTGTTAATATAGTGAAAAG-3′ | 55 |
| Ala: 99, 81 |
| R:5′- TACCCTGAGTTCAGTTCCGTC-3′ | Thr: 180 |
Annealing temperature.
Restriction enzyme.
Enzyme-digested size.
Forward primer.
Reverse primer.
ORs and 95%CIs of main risk factors for CRC.
| Variable | Cases N(%) | Controls N(%) | OR (95%CI) | P |
| Family per capita annual income (yuan/year) | ||||
| <10000 | 134(33.5) | 118(29.5) | Reference | 0.211 |
| ≥10000 | 266(66.5) | 282(70.5) | 0.819 (0.598–1.120) | |
| Family history of CRC | ||||
| No | 365(91.2) | 391(97.8) | Reference | 0.001 |
| Yes | 35(8.8) | 9(2.2) | 3.808 (1.775–8.171) | |
| Sitting hours per day | ||||
| <8 | 296(74.0) | 337(84.2) | Reference | 0.002 |
| ≥8 | 104(26.0) | 63(15.8) | 1.810 (1.250–2.620) | |
| BMI | ||||
| <24 | 245(61.2) | 231(57.8) | Reference | 0.372 |
| ≥24 | 155(38.8) | 169(42.2) | 0.874 (0.651–1.174) | |
| Smoking habit | ||||
| No | 226(56.5) | 230(57.5) | Reference | 0.485 |
| Yes | 174(43.5) | 170(42.5) | 1.135 (0.795–1.622) | |
| Alcohol-drinking habit | ||||
| No | 262(65.5) | 259(64.8) | Reference | 0.564 |
| Yes | 138(34.5) | 141(35.2) | 0.899 (0.626–1.291) | |
| Tea-drinking habit | ||||
| No | 228(57.0) | 190(47.5) | Reference | 0.003 |
| Yes | 172(43.0) | 210(52.5) | 0.617 (0.451–0.844) | |
| Red meat(times/week) | ||||
| ≤7 | 144(36.0) | 214(53.5) | Reference | <0.001 |
| >7 | 256(64.0) | 186(46.5) | 1.870 (1.392–2.512) |
Association between ADIPOQ rs2241766, UCP2 rs659366, FABP2 rs1799883 and CRC risk.
| Genotype | Cases N(%) | Controls N(%) | OR | P | |
| rs2241766 | |||||
| TT | 173(43.2) | 208(52.0) | Reference | 0.064 | |
| TG | 196(49.0) | 165(41.2) | 1.420(1.050–1.921) | 0.023 | |
| GG | 31(7.8) | 27(6.8) | 1.384(0.782–2.451) | 0.265 | |
| TG+GG | 227(56.8) | 192(48.0) | 1.429(1.069–1.909) | 0.016 | |
| rs659366 | |||||
| GG | 147(36.8) | 137(34.3) | Reference | 0.423 | |
| GA | 184(46.0) | 202(50.5) | 0.839(0.610–1.152) | 0.277 | |
| AA | 69(17.2) | 61(15.2) | 1.047(0.682–1.609) | 0.833 | |
| GA+AA | 253(63.2) | 263(65.8) | 0.888(0.658–1.197) | 0.435 | |
| rs1799883 | |||||
| Ala/Ala | 230(57.5) | 226(56.5) | Reference | 0.759 | |
| Ala/Thr | 139(34.8) | 142(35.5) | 0.893(0.656–1.216) | 0.472 | |
| Thr/Thr | 31(7.7) | 32(8.0) | 0.909(0.526–1.570) | 0.731 | |
| Ala/Thr+Thr/Thr | 170(42.5) | 174(43.5) | 0.899(0.672–1.201) | 0.470 | |
Adjusted by confounding factors, including family per capita annual income, family history of CRC, sitting hours per day, BMI, smoking habit, alcohol-drinking habit and tea-drinking habit.
Gene-gene interaction for ADIPOQ rs2241766, UCP2 rs659366, and FABP2 rs1799883 on CRC risk.
| Genotype | Genotype | Ca/Co | OR | P | ORmulti
| Pmulti |
| rs2241766 | rs659366 | |||||
| TT | GA+AA | 114/138 | Reference | 1.308(0.716–2.389) | 0.382 | |
| TG+GG | GA+AA | 139/125 | 1.287(0.900–1.841) | 0.166 | ||
| TT | GG | 59/70 | 0.975(0.629–1.511) | 0.910 | ||
| TG+GG | GG | 88/67 | 1.642(1.084–2.486) | 0.019 | ||
| rs2241766 | rs1799883 | |||||
| TT | Ala/Thr+Thr/Thr | 73/74 | Reference | 2.031(1.131–3.646) | 0.017 | |
| TG+GG | Ala/Thr+Thr/Thr | 97/100 | 0.959(0.617–1.489) | 0.851 | ||
| TT | Ala/Ala | 100/134 | 0.763(0.499–1.166) | 0.211 | ||
| TG+GG | Ala/Ala | 130/92 | 1.485(0.964–2.289) | 0.073 | ||
| rs659366 | rs1799883 | |||||
| GA+AA | Ala/Thr+Thr/Thr | 109/110 | Reference | 1.354(0.741–2.475) | 0.324 | |
| GG | Ala/Thr+Thr/Thr | 61/64 | 0.962(0.613–1.511) | 0.867 | ||
| GA+AA | Ala/Ala | 144/153 | 0.966(0.673–1.386) | 0.851 | ||
| GG | Ala/Ala | 86/73 | 1.259(0.826–1.919) | 0.285 |
Cases and controls.
Adjusted by confounding factors, including family per capita annual income, family history of CRC, sitting hours per day, BMI, smoking habit, alcohol-drinking habit and tea-drinking habit.
GMDR models of high order interaction on CRC risk.
| Model | Prediction Error | P | Cross-validation Consistency |
|
| |||
| rs2241766 | 0.4559 | 0.0547 | 10/10 |
| rs2241766, rs1799883 | 0.4769 | 0.0547 | 8/10 |
| rs2241766, rs1799883, rs659366 | 0.4538 | 0.0107 | 10/10 |
|
| |||
| Red meat | 0.4141 | 0.0010 | 10/10 |
| rs2241766, Red meat | 0.4141 | 0.0010 | 10/10 |
| rs2241766, rs659366, Red meat | 0.4436 | 0.0107 | 6/10 |
| rs2241766, rs1799883, rs659366, Red meat | 0.4289 | 0.0107 | 10/10 |
Adjusted by covariate, including family per capita annual income, family history of CRC, sitting hours per day, BMI, smoking habit, alcohol-drinking habit and tea-drinking habit.
Gene-environment interaction for each of ADIPOQ rs2241766, UCP2 rs659366, FABP2 rs1799883 and red meat consumption on CRC risk.
| Genotype | red meat (times/week) | Ca/Co | OR | P | ORmulti
| Pmulti |
| rs2241766 | ||||||
| TT | ≤7 | 67/110 | Reference | 1.222(0.682–2.190) | 0.500 | |
| TG+GG | 77/104 | 1.251 (0.810–1.932) | 0.312 | |||
| TT | >7 | 106/98 | 1.672 (1.100–2.543) | 0.016 | ||
| TG+GG | 150/88 | 2.558 (1.692–3.866) | <0.001 | |||
| rs659366 | ||||||
| GA+AA | ≤7 | 91/133 | Reference | 1.422(0.773–2.616) | 0.256 | |
| GG | 53/81 | 0.967 (0.619–1.512) | 0.884 | |||
| GA+AA | >7 | 162/130 | 1.661 (1.154–2.393) | 0.006 | ||
| GG | 94/56 | 2.286 (1.475–3.543) | <0.001 | |||
| rs1799883 | ||||||
| Ala/Thr+Thr/Thr | ≤7 | 68/100 | Reference | 1.095(0.608–1.971) | 0.763 | |
| Ala/Ala | 76/114 | 0.973 (0.632–1.498) | 0.900 | |||
| Ala/Thr+Thr/Thr | >7 | 102/74 | 1.773 (1.134–2.771) | 0.012 | ||
| Ala/Ala | 154/112 | 1.888 (1.261–2.827) | 0.002 |
Cases and controls.
Adjusted by confounding factors, including family per capita annual income, family history of CRC, sitting hours per day, BMI, smoking habit, alcohol-drinking habit and tea-drinking habit.
Cumulative effects of risk genotypes of ADIPOQ rs2241766, UCP2 rs659366, and FABP2 rs1799883 combined with red meat consumption on CRC risk.
| Total | Low-red meat (≤7 times/week) | High-red meat (>7 times/week) | |||||||
| No. | Ca/Co | OR | P | Ca/Co | OR | P | Ca/Co | OR | P |
| 0 | 46/50 | Reference | 20/26 | Reference | 26/24 | 1.194 (0.525–2.715) | 0.672 | ||
| 1 | 158/172 | 0.920 (0.576–1.467) | 0.725 | 59/92 | 0.743 (0.375–1.469) | 0.392 | 99/80 | 1.321 (0.675–2.585) | 0.417 |
| 2 | 142/151 | 0.992 (0.619–1.591) | 0.973 | 48/81 | 0.704 (0.350–1.415) | 0.325 | 94/70 | 1.514 (0.772–2.970) | 0.228 |
| 3 | 54/27 | 2.243 (1.196–4.207) | 0.012 | 17/15 | 1.571 (0.619–3.987) | 0.342 | 37/12 | 3.439 (1.410–8.385) | 0.007 |
The number of risk genotypes which were defined as ADIPOQ rs2241766 TG+GG, UCP2 rs659366 GG, and FABP2 rs1799883 Ala/Ala.
Cases and controls.
Adjusted by confounding factors, including family per capita annual income, family history of CRC, sitting hours per day, BMI, smoking habit, alcohol-drinking habit and tea-drinking habit.